Human Thrombin Activatable Fibrinolysis Inhibitor

<strong>Human Thrombin Activatable Fibrinolysis Inhibitor</strong>_x000D_ <strong>Catalog number:</strong> B2016562_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 60000_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −80°C_x000D_ <strong>Keywords:</strong> Thrombin Activatable Fibrinolysis Inhibitor (human)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Sillen M, Declerck PJ. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review Int J Mol Sci. 2021 Apr 1;22(7):3670._x000D_ 2: Bridge KI, Bollen L, Zhong J, Hesketh M, Macrae FL, Johnson A, Philippou H, Scott DJ, Gils A, Ariёns RAS. Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease J Thromb Haemost. 2017 Nov;15(11):2218-2225._x000D_ 3: Vanassche T, Rosovsky RP, Moustafa F, Büller HR, Segers A, Patel I, Shi M, Miyoshi N, Mani V, Fayad Z, Stephan D, Schmidt J, Grosso MA, Tapson VF, Verhamme P, Huisman MV; of the DS-1040 Study Group. Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study J Thromb Haemost. 2023 Oct;21(10):2929-2940._x000D_ 4: Foley JH, Kim PY, Mutch NJ, Gils A. Insights into thrombin activatable fibrinolysis inhibitor function and regulation J Thromb Haemost. 2013 Jun;11 Suppl 1:306-15._x000D_ 5: Marx PF. Thrombin-activatable fibrinolysis inhibitor Curr Med Chem. 2004 Sep;11(17):2335-48._x000D_ 6: Yıldız A, Katar D, Soydaş AÖ, Albayrak M. Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism Hamostaseologie. 2022 Jun;42(3):180-184._x000D_ 7: Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:74-8._x000D_ 8: Declerck PJ. Thrombin activatable fibrinolysis inhibitor Hamostaseologie. 2011 Aug;31(3):165-6, 168-73._x000D_ 9: Plug T, Meijers JC. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor J Thromb Haemost. 2016 Apr;14(4):633-44._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/17008302">10: Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis? Ann Med. 2006;38(6):378-88. </a>_x000D_ _x000D_ <strong>Products Related to Human Thrombin Activatable Fibrinolysis Inhibitor can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>